Day: December 6, 2022

LOS ANGELES, Dec. 06, 2022 (GLOBE NEWSWIRE) — via InvestorWire – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announces it has selected the corporate communications expertise of IBN, a multifaceted financial news and publishing company for private and public entities. In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, BiondVax is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis. NanoAbs,...

Network-on-chip interconnect IP to develop a variety of automotive systems-on-chip because of proven performance, low power and security. CAMPBELL, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced its collaboration with Telechips to integrate the Arteris FlexNoC interconnect IP established technology into several SoC products for automotive. The new designs are based on the latest automotive safety standards, including ISO 26262, ASIL B and ASIL D. The products ensure security requirements are met when designing Telechips’ new business area solutions like advanced driver-assistance systems (ADAS) and microcontroller units (MCUs). Arteris interconnect IP capabilities enable Telechips SoCs to achieve the low power,...

TORONTO, Dec. 06, 2022 (GLOBE NEWSWIRE) — ARHT Media Inc. has today at CineAsia, Bangkok, announced an agreement to install 10 CAPSULE holographic displays at market leading Indian cinema operator PVR’s movie theatres. The agreement is expected to result in four locations being installed in Q4 2022 and 6 additional locations in Q1 2023. PVR is known throughout India for technological innovation as well as curating unique and memorable experiences for their guests. This commitment to be the first cinema operator in India to offer holographic 3D experiences to audiences further builds on that legacy. The technology will provide PVR audiences with an immersive experience that goes beyond the big screen, offering the opportunity to get up close to live and pre-recorded hologrammatic versions of their favorite movie stars in cinema...

CALGARY, Alberta, Dec. 06, 2022 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company”) a North American leading manufacturer and supplier of technologically advanced cellular concrete products, today announced that it will host a webcast investor presentation on Tuesday, December 13, 2022 at 2:00 PM ET. During the webcast, Jeff Kendrick, CEO will conduct a PowerPoint presentation that will cover key areas of CEMATRIX’s business. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal. To listen to the webcast or to ask questions during the live event, please pre-register at the following link: https://event.webcasts.com/starthere.jsp?ei=1584777&tp_key=9b5acb19b9 An archived version of...

AUSTIN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, announced today that its Smart Hospitality Solution is being launched at Wailea Beach Resort – Marriott, Maui, which is part of the Marriott International, Inc. (NASDAQ: MAR) (“Marriott”) portfolio of brands. Wailea Beach Resort, the epitome of scenic luxury spanning 22 meticulously landscaped acres, is situated between two sandy beaches along Maui’s southern coastline with 547 residential-style rooms and suites. The resort underwent a $100 million renovation and boasts a 9,000+ square-foot spa, renowned Te Au Moana luau and dining options that range from the signature Humble Market Kitchin by Celebrity...

– Dr. Craig Hopkinson, currently EVP of Research & Development and Chief Medical Officer at Alkermes, brings strong global orphan drug development expertise – Dr. Paul Streck, former Chief Medical Officer at Arena Pharmaceuticals, brings significant global drug development and commercialization expertise – Two appointments strengthen Company’s ability to scale up global drug development and grow the portfolio BOSTON, Dec. 06, 2022 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators to treat pediatric and adult liver diseases, today announced the appointments of two scientific leaders, Drs. Paul Streck and Craig Hopkinson, to the Enterprise Leadership Team and Board of Directors, respectively. These appointments coincide with an important time for Albireo...

BERKELEY HEIGHTS, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced the abstract publication and poster presentation at the American Society of Health-System Pharmacists (ASHP) conference in Las Vegas, Nevada, December 4 – 8. The abstract being presented highlights research that was conducted by integrating multiple clinical and claims databases that track a large cohort of kidney failure patients on hemodialysis (HD) with central venous catheters (CVCs). The conclusions from this retrospective study further underscore the significant mortality risk and long-term complications associated with catheter-related bloodstream infections...

Edible Garden Products to be Available in 29 Gristedes and D’Agostino retail locations, situated in densely populated, high-traffic Urban Areas, in Manhattan, Brooklyn and Westchester Counties BELVIDERE, NJ, Dec. 06, 2022 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, today announced an expansion of its distribution with Gristedes and D’Agostino supermarkets to sell Edible Garden products in 29 of their combined locations in Manhattan, Brooklyn and Westchester. In addition to an expansion of the distribution network, Edible Garden plans to collaborate with Gristedes and D’Agostino on the display and strategic placement of Edible Garden’s products within their...

Studies are Supported and Funded Through Cooperative Agreement Grants from the National Cancer Institute GFH009 to be Evaluated Against Pediatric Solid Tumors and Leukemia Models at Eight Participating Research Institutions NEW YORK, Dec. 06, 2022 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that SELLAS’ highly selective CDK9 inhibitor, GFH009, will be evaluated in pediatric solid tumors and leukemia models through the National Cancer Institute (NCI) Pediatric Preclinical in Vivo Testing (PIVOT) Program. GFH009 testing through the program involves a two-phase research plan for pharmacokinetics (PK) and efficacy in pediatric tumors....

CINCINNATI, Dec. 06, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced the Company will host an online Key Opinion Leader (“KOL”) event on Wednesday, December 7, 2022 from 12 p.m. – 2 p.m. EST. To kick off the event, Joseph Hernandez, Chairman and Chief Executive Officer of Blue Water Vaccines, will provide a brief Company overview and deliver a welcome message to participants. Following this introduction, Ali Fattom, Ph.D., will give an introduction to vaccines, the importance and benefits of vaccines that elicit mucosal immunity, the current pneumococcal vaccine landscape, and the need for an efficacious, intranasal pneumococcal vaccine. Then, Jason...